Thursday 25 July 2024

Curvebeam AI (ASX:CVB): Developing enhancements to the HiRise™ platform

Curvebeam AI (ASX:CVB) is building artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. The current focus of management is to support its U.S. growth strategy and further its Stryker partnership | Investor presentation:

Free stock updates

Subscribe to receive the latest stock news, CEO interviews, expert insights, events and offers directly into your inbox